GVR Report cover Immune Health Supplements Market Size, Share & Trends Report

Immune Health Supplements Market Size, Share & Trends Analysis Report By Product, By Form, By Application, By Mode Of Medication, By Distribution Channel, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68039-548-0
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview 

The global immune health supplements market size was valued at USD 55.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028. The key factors driving market growth include the increasing prevalence of infectious diseases, diabetes, and several other disorders due to lack of immunity. In recent years, there is a constant trend observed about the increase in supplement usage to improve the body's immunity all over the globe.

Due to the COVID19 pandemic, there is significant consumer interest in the use of immune health supplements. In 2019, according to the Council for Responsible Nutrition (CRN), about 73% of Americans consume dietary supplements and from that, about 32% are consuming the dietary supplements to improve their immune health. The increasing consumer awareness to maintain and improve immune health and wellbeing is expected to drive the market over the forecast years.


U.S. immune health supplements market size, by product, 2018 - 2028 (USD Billion)

Supplement products, such as vitamins, minerals, herbal products, and probiotics, for boosting immunity have witnessed a high demand in recent years. Population across the globe is now more conscious about their immune health and quality of life. The rising aging population and the growing awareness among adult individuals to boost the body's immunity have increased the demand for immune health supplements that supports market growth.

Immune health supplements have a significant impact on enhancing the body's immune system and aids in the protection from various infectious diseases. Several studies show that diabetes has a direct correlation with the occurrence of chronic diseases. It also increases the risk of infectious disease. Hence, there is a growing interest in the consumption of supplements among diabetic patients to improve their immune system, which can provide a significant value to combat infectious diseases.

The COVID19 outbreak has had a positive impact on market growth. The regions, such as North America, Europe, and the Asia Pacific, have been highly affected due to the COVID19 pandemic. The countries, such as the U.S., U.K., India, Russia, France, having the highest number of COVID19 cases. A large population and the increasing adoption of supplements to increase the body's immune system in these regions are anticipated to drive the market over the forecast years.

COVID-19 Global immune health supplements market impact: 1.0% increase in revenue growth from 2019 to 2020

Pandemic Impact

Post COVID Outlook

The global immune health supplements market increased by 1.0% from 2019 to 2020

The market is estimated to witness a year-on-year growth of approximately 11.0 % to 12.0% in the next five years.

Coronavirus pandemic has significantly increased the interest of the consumers to peak vitamin and mineral supplements for their immune health. There is a spike in demand for Immunity boosting products due to the coronavirus pandemic.

Increasing consumer consciousness towards their immune health due to this life-threatening coronavirus disease and strategic initiatives by the manufacturers to develop novel products are the key factors expected to bolster the market growth during the post-COVID-19 outbreak.

The pandemic also creates new consumers globally for immunity-boosting products. There is also a shifting of priorities to better immune health across the globe seems to be at an all-time high which, in turn, has positively impacted market growth.

The increasing prevalence of COVID-19 and several other infectious diseases and rising demand for immunity-boosting supplements are anticipated to drive their adoption in the coming years.


Furthermore, several manufacturers are now increased their manufacturing capacity to fulfill the rising demand for immunity-boosting supplements. Manufacturers are also investing more towards the development of new immune health supplements to attract consumers. In 2019, Swisse Wellness, an Australian manufacturer, introduced an Immune Support Jelly contains Zinc, Elderberry, Selenium and Manuka Honey in an Orange Passionfruit flavor to boost healthy immune function.

Product Insights

The vitamin and mineral supplement segment dominated the market and accounted for the largest revenue share of 64.5% in 2020. Increasing preference for supplements among consumers across the globe to boost their immunity is driving the segment. The proven health benefits and wide availability of vitamin C, D, B complex, multivitamins, and the minerals, such as zinc and selenium, in supporting the immune system propelling the segment growth. Vitamin C sales seem to be higher after the COVID-19 pandemic all over the globe. Due to the increasing awareness towards using preventive measures by the individuals is expected to accelerate the segment growth during forecast periods.

The herbal supplement segment is expected to witness a CAGR of over 12.0% during the forecast period. High demand among consumers to use herbal supplements over nutraceuticals to enhance the body’s immune health without any side effects driving the segment. Besides the rise in the vegan population is also anticipated to drive the segment over the forecast years.

Form Insights

The tablet segment dominated the market and accounted for the largest revenue share of 32.8% in 2020. Most of the vendors are manufacturing supplements in tablet formulation due to their higher shelf life, low cost, and higher convenience. Further increasing popularity of immune health supplements in the form of tablets due to easy and well-defined dosage is also anticipated to drive the segment during the forecast period.

The softgels segment is expected to exhibit the highest CAGR of 12.4 % over the forecast period. This growth is attributed to the easy route of administration offered by the gels to consume vitamins and minerals.

Application Insights

The respiratory tract infection segment dominated the market and accounted for the largest revenue share of 36.8% in 2020. The demand for the use of immune health supplements has been showing off an extraordinary growth since the COVID19 pandemic. Globally peoples are much more cautious to maintain a healthy immune system by using supplements to protect themselves from life-threatening diseases, such as COVID-19 due to acute respiratory tract infections.

The gut health segment is anticipated to become the second-highest revenue contributor to the market over the forecast period. Many studies reported that the gut microbiome plays an important role to maintain the body's innate and adaptive immunity. The inflammation and infection in COVID-19 patients tend to cause an imbalance in the intestinal flora or helpful bacteria as part of the treatment process. This imbalance of gut microbiota can influence the body's immunity, and also hampers overall health and wellness. Therefore, increasing preference for immune health supplements to maintain gut health is expected to drive this segment over the forecast years.

Mode Of Medication Insights 

The self-medication segment dominated the market and accounted for the highest revenue share of 67.5% in 2020. The supplements for boosting immunity do not require a prescription to purchase from a drug store, which is anticipated to provide the highest revenue share for this segment by mode of medication and its trend is expected to continue over the forecast years. In addition, rising consumer awareness due to the COVID-19 pandemic is also expected to boost the revenue share of the self-medication segment over the years than prescription-based medication.

Distribution Channel Insights

The pharmacies/drug stores segment dominated the market and accounted for the largest revenue share of 58.9% in 2020. Rising consumer preference and availability of a wide variety of products is expected to augment the highest sale of the products in pharmacies or drug stores. The supermarket/hypermarkets held significant revenue share in 2020 owing to high discounts and the availability of a wide range of products in North America and Europe regions. Besides, an increasing number of supermarkets in developing countries is also anticipated to drive the growth of the segment during the forecast years.

Global immune health supplements market share, by distribution channel, 2020 (%)

However, the e-commerce segment is expected to witness a CAGR of 12.1% over the forecast period owing to the growing usage of e-commerce channels to purchase supplements. Furthermore, a rapid increase in the number of e-commerce vendors due to the COVID-19 pandemic is also expected to drive the segment over the forecast period.

Regional Insights

As of 2020, North America dominated the market and accounted for the largest revenue share of 37.1% in 2020. The highest consumer base for immune health supplements and growing awareness among the individuals are the factors anticipated to fuel the regional growth in the immune health supplements market over the forecast years. In addition, an increasing trend in the U.S. population to invest in preventive supplements is also expected to drive the market growth in this region.

In Asia Pacific, the market is also estimated to witness the fastest CAGR of 12.8% during the forecast period. Growing per capita income, increasing consumer base in Asian countries such as China, India, and South Korea is anticipated to drive the demand for immune health supplements in these regions over the forecast years. Besides, growing awareness and expenditure on health-enhancing products also are the key factors for the fastest growth of this region over the forecast years.

Europe accounted for the second-highest revenue share in the market in 2020. Various government initiatives to boost the immunity due to COVID19 among the population and the growing awareness are the factors for the significant revenue share of this region. In addition, higher per capita income in the European countries such as U.K., Germany, France and increasing expenditure by the individuals on supplements to improve their immune health are the major factors anticipated to the significant market growth in this region.

Key Companies & Market Share Insights

Key players are mainly focusing on new product innovation and development to hold a strong base in the global market. For instance, In April 2019, Bayer AG launched a new redox on triple-action supplement to overcome immunity challenges during the Ramadan fasting period. In December 2020, Abbott developed a new Pedialyte hydration solution to support immune health. Pedialyte with Immune Support includes prebiotics, vitamin B12, vitamin C, vitamin E, and zinc, which are nutrients specifically chosen because of their role in supporting the immune system. Some of the prominent players in the immune health supplements market include:

  • Bayer AG

  • Pfizer Inc.

  • Sun Pharmaceutical Industries Limited

  • Swisse Wellness Pty Ltd.

  • GlaxoSmithKline Inc.

  • Abbott Laboratories

  • Amway Corp.

  • The Nature's Bounty Co.

  • Herbalife Nutrition of America, Inc.

  • Himalaya Global Holdings Ltd.

  • American Health

  • Unilever

  • Sanofi

  • Novartis

  • Boehringer Ingelheim

  • Nestlè

  • Danone

Immune Health Supplements Market Report Scope

Report Attribute


Market size value in 2021

USD 62.5 billion

Revenue forecast in 2028

USD 132.0 billion

Growth rate

CAGR of 11.3% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, form, application, mode of medication, distribution channel, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; Singapore; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Bayer AG; Pfizer Inc.; Sun Pharmaceutical Industries Limited; Swisse Wellness Pty Ltd; GlaxoSmithKline Inc.; Abbott Laboratories; Amway Corp.; The Nature's Bounty Co.; Herbalife Nutrition of America, Inc.; Himalaya Global Holdings Ltd.; American Health; Unilever; Sanofi; Novartis; Boehringer Ingelheim; Nestlè; Danone

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments covered in the report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global immune health supplements market report on the basis of product, form, application, mode of medication, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Vitamin and Mineral Supplements

      • Vitamin C Supplements

      • Vitamin D Supplements

      • Vitamin B complex Supplements

      • Multivitamins

      • Selenium Supplements

      • Zinc Supplements

      • Others

    • Herbal Supplements

    • Probiotic Supplements 

    • Others

  • Form Outlook (Revenue, USD Million, 2016 - 2028)

    • Capsules

    • Tablets

    • Powder

    • Liquid

    • Gel

    • Soft gels

    • Others

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Hair growth

    • Gut health

    • Respiratory tract infection

    • Others

  • Mode Of Medication Outlook (Revenue, USD Million, 2016 - 2028)

    • Prescription based

    • Self-medication

  • Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

    • Pharmacies/Drug Stores

    • Supermarkets and Hypermarkets

    • E-commerce

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Singapore

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.